Retina/Vitreous News

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Michael H. Goldstein, MD, of Aurion Biotech discusses studies exploring the use of human corneal endothelial cells for corneal edema secondary to endothelial dysfunction.

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Carl D. Regillo, MD, discusses promising results for the Ixo-vec gene therapy for neovascular age-related macular degeneration.

FORT LAUDERDALE, Fla. — Social and political determinates of health must be addressed to provide all patients with better visual outcomes, according to a speaker at the Retina World Congress.

Male sex, Black race and insurance coverage with Medicaid were among factors associated with increased risk for developing 20/200 or worse vision among children with juvenile idiopathic arthritis-associated uveitis, according to research.

SEATTLE — In this Healio Video Perspective from the Retina World Congress, David Almeida, MD, MBA, PhD, discusses combating gene therapy-associated uveitis.

FORT LAUDERDALE, Fla. — The first-in-human bimanual vitrectomy performed with a robot at Ghent University Hospital, Belgium, was presented here at the Retina World Congress.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Dolly Shuo-Teh Chang, MD, of Genentech discusses the effect of intraretinal fluid volume reduction on anatomical and visual outcomes in diabetic macular edema.

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Christine Kay, MD, discusses MCO-010, a gene-agnostic therapy for patients with advanced retinitis pigmentosa.

FORT LAUDERDALE, Fla. — Autoimmune retinopathy is a rare disease that is difficult to diagnose because of the near absence of clinical findings, symptom overlap with those of other diseases and limited, nonstandardized diagnostic criteria.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Jaclyn L. Kovach, MD, discusses the beneficial effects on macular function of continuous pegcetacoplan treatment in geographic atrophy.